Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar-Apr;51(2):e70017.
doi: 10.1002/biof.70017.

A novel peptide derived from Haematococcus pluvialis residue balanced lipid metabolism through NHR-49/PPARα and AAK-2/AMPK pathways in Caenorhabditis elegans

Affiliations

A novel peptide derived from Haematococcus pluvialis residue balanced lipid metabolism through NHR-49/PPARα and AAK-2/AMPK pathways in Caenorhabditis elegans

Liang Ke et al. Biofactors. 2025 Mar-Apr.

Abstract

To explore the potential value of Haematococcus pluvialis residue after astaxanthin extraction, a novel peptide (HPp) was identified as a bioactive component. However, the possible lipid-lowering effect in vivo remains unclear. Thus, the classic model of Caenorhabditis elegans (C. elegans) was employed to evaluate the anti-obesity effects and underlying mechanism. The results showed that 100 μM HPp significantly reduced the overall fat and triglyceride contents, while also remarkably decreasing the lipid droplets size and promoting desaturation of C18:0 to C18:1n9. Subsequent analysis indicated that HPp increased energy expenditure and alleviated intestinal distension. Further molecular research revealed that HPp activated the gene expression of fat-6, fat-7, nhr-49, acs-2, aak-2, atgl-1. Notably, the lipid-lowering effects were abolished in fat-6, fat-7, nhr-49 mutants, and further verified in GFP-tagged nematodes, indicating that HPp balanced lipid metabolism by activating NHR-49/PPARα and AAK-2/AMPK pathways in C. elegans. These findings highlight the high-value applications of marine microalgae.

Keywords: AAK‐2/AMPK; Caenorhabditis elegans; Haematococcus pluvialis peptide; NHR‐49/PPARα; anti‐obesity; lipid metabolism.

PubMed Disclaimer

Similar articles

References

REFERENCES

    1. Sørensen TIA. Forecasting the global obesity epidemic through 2050. Lancet. 2025;405:10481.
    1. Liu L, Li Z, Ye W, Peng P, Wang Y, Wan L, et al. Safety and effects of anti‐obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta‐analysis. Eclinicalmedicine. 2025;79:103020.
    1. Nieri P, Carpi S, Esposito R, Costantini M, Zupo V. Bioactive molecules from marine diatoms and their value for the nutraceutical industry. Nutrients. 2023;15(2):464–486. https://doi.org/10.3390/nu15020464
    1. Zhou L, Li K, Duan X, Hill D, Barrrow C, Dunshea F, et al. Bioactive compounds in microalgae and their potential health benefits. Food Biosci. 2022;49:101932. https://doi.org/10.1016/j.fbio.2022.101932
    1. Teng Z, Zheng L, Yang Z, Li L, Zhang Q, Li L, et al. Biomass production and astaxanthin accumulation of Haematococcus pluvialis in large‐scale outdoor culture based on year‐round survey: influencing factors and physiological response. Algal Res. 2023;71:103070.

MeSH terms

LinkOut - more resources